Encompass Health Corporation (EHC) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $106.70. It has a SharesGrow Score of 70/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of EHC = $88.55 (-17% from the current price, the stock appears overvalued). Analyst consensus target is EHC = $153 (+43.4% upside).
Valuation: EHC trades at a trailing Price-to-Earnings (P/E) of 18.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.02.
Financials: revenue is $5.9B, +10.9%/yr average growth. Net income is $566M, growing at +27.9%/yr. Net profit margin is 9.5% (thin). Gross margin is 21.7% (-73.7 pp trend).
Balance sheet: total debt is $2.7B against $2.4B equity (Debt-to-Equity (D/E) ratio 1.11, moderate). Current ratio is 1.08 (adequate). Debt-to-assets is 38.3%. Total assets: $7.1B.
Analyst outlook: 21 / 26 analysts rate EHC as buy (81%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 52/100 (Partial), Growth 90/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 44/100 (Fail), Future 94/100 (Pass), Income 45/100 (Partial).
